3 min read
Simon van der Pol: 21 September 2026, 16:27:08 CEST
A new cost-effectiveness analysis finds that the next-generation vaccine mRNA-1283 could prevent thousands more hospitalisations and deaths than the...
2 min read
Replacing standard-dose with adjuvanted influenza vaccination in adults aged 60 and over, and in high-risk adults aged 50–59, could prevent hundreds...
2 min read
Tanja Fens: 24 June 2026, 14:12:34 CEST
Updated health-economic evidence, drawing on data from more than 85 million individuals, confirms that switching from standard-dose to high-dose...